Tower Research Capital LLC TRC Raises Position in Integer Holdings Co. (NYSE:ITGR)

Tower Research Capital LLC TRC raised its stake in Integer Holdings Co. (NYSE:ITGR - Free Report) by 123.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 4,459 shares of the medical equipment provider's stock after purchasing an additional 2,465 shares during the period. Tower Research Capital LLC TRC's holdings in Integer were worth $591,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Lord Abbett & CO. LLC grew its stake in shares of Integer by 3.5% during the 3rd quarter. Lord Abbett & CO. LLC now owns 290,120 shares of the medical equipment provider's stock worth $37,716,000 after acquiring an additional 9,754 shares during the period. Versant Capital Management Inc increased its position in shares of Integer by 98.4% in the fourth quarter. Versant Capital Management Inc now owns 369 shares of the medical equipment provider's stock valued at $49,000 after acquiring an additional 183 shares during the period. GAMMA Investing LLC increased its position in Integer by 36.0% during the 4th quarter. GAMMA Investing LLC now owns 888 shares of the medical equipment provider's stock valued at $118,000 after purchasing an additional 235 shares during the period. Park Avenue Securities LLC raised its holdings in Integer by 26.0% in the fourth quarter. Park Avenue Securities LLC now owns 4,710 shares of the medical equipment provider's stock worth $624,000 after purchasing an additional 972 shares in the last quarter. Finally, Contravisory Investment Management Inc. boosted its stake in Integer by 210.8% during the fourth quarter. Contravisory Investment Management Inc. now owns 693 shares of the medical equipment provider's stock worth $92,000 after acquiring an additional 470 shares in the last quarter. 99.29% of the stock is owned by institutional investors and hedge funds.

Integer Stock Performance

Shares of ITGR traded up $0.05 during trading hours on Friday, hitting $125.64. The stock had a trading volume of 569,808 shares, compared to its average volume of 352,261. The company has a debt-to-equity ratio of 0.62, a quick ratio of 2.09 and a current ratio of 2.95. Integer Holdings Co. has a fifty-two week low of $104.93 and a fifty-two week high of $146.36. The firm has a 50-day moving average price of $118.89 and a 200 day moving average price of $130.14. The firm has a market capitalization of $4.38 billion, a price-to-earnings ratio of 37.39, a PEG ratio of 1.72 and a beta of 1.09.

Integer (NYSE:ITGR - Get Free Report) last announced its quarterly earnings data on Thursday, April 24th. The medical equipment provider reported $1.31 earnings per share for the quarter, beating analysts' consensus estimates of $1.27 by $0.04. Integer had a return on equity of 11.65% and a net margin of 6.92%. The company had revenue of $437.39 million for the quarter, compared to analyst estimates of $428.51 million. During the same quarter last year, the firm posted $1.14 EPS. The firm's revenue for the quarter was up 7.3% on a year-over-year basis. As a group, research analysts anticipate that Integer Holdings Co. will post 6.01 EPS for the current year.

Analyst Upgrades and Downgrades

ITGR has been the subject of a number of recent analyst reports. Oppenheimer lowered Integer from an "outperform" rating to a "market perform" rating in a research report on Friday, February 21st. Benchmark cut their target price on shares of Integer from $150.00 to $140.00 and set a "buy" rating for the company in a report on Friday, April 25th. StockNews.com downgraded shares of Integer from a "hold" rating to a "sell" rating in a report on Friday, April 25th. Raymond James raised their price objective on Integer from $145.00 to $150.00 and gave the stock an "outperform" rating in a report on Friday, April 25th. Finally, Truist Financial set a $150.00 price objective on Integer and gave the company a "buy" rating in a research report on Friday, April 25th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and seven have given a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $145.56.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.